Data / Form D filings / Celcuity Inc.
Celcuity Inc.: Form D filings
Celcuity Inc., a biotechnology company in Minneapolis, MN, filed 30 Form D notices with the SEC between 2014 and 2025. The latest, on September 23, 2025, reports $130 million sold of a $352.7 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16305 36TH AVENUE NORTH, SUITE 100, Minneapolis, MN, 55446
- Phone
- (763) 392-0767
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1603454
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | Amendment | $352,700,000 | $130,000,000 | $222,700,000 | 2 | Apr 8, 2021 | sec.gov |
| Oct 15, 2024 | Amendment | $50,000,000 | $50,000,000 | 2 | Oct 20, 2023 | sec.gov | |
| Jun 28, 2024 | Amendment | $184,500,000 | $100,000,000 | $84,500,000 | 2 | Apr 8, 2021 | sec.gov |
| Apr 25, 2024 | Amendment | $75,375,000 | $35,000,000 | $40,375,000 | 1 | Apr 8, 2021 | sec.gov |
| Nov 27, 2023 | Amendment | $2,975,746 | $2,597,057 | $378,689 | 38 | May 5, 2017 | sec.gov |
| Nov 27, 2023 | Amendment | $6,612,667 | $5,930,006 | $682,661 | 39 | Apr 28, 2017 | sec.gov |
| Oct 26, 2023 | New notice | $50,000,000 | $50,000,000 | 2 | Oct 20, 2023 | sec.gov | |
| May 2, 2023 | Amendment | $75,375,000 | $35,000,000 | $40,375,000 | 1 | Apr 8, 2021 | sec.gov |
| Nov 28, 2022 | Amendment | $6,612,667 | $5,930,006 | $682,661 | 39 | Apr 28, 2017 | sec.gov |
| Nov 28, 2022 | Amendment | $2,975,746 | $2,597,057 | $378,689 | 38 | May 5, 2017 | sec.gov |
| May 26, 2022 | New notice | $155,999,997 | $99,999,998 | $55,999,999 | 11 | May 15, 2022 | sec.gov |
| Apr 8, 2022 | Amendment | $25,625,000 | $15,000,000 | $10,625,000 | 1 | Apr 8, 2021 | sec.gov |
| Nov 22, 2021 | Amendment | $2,975,746 | $2,597,057 | $378,689 | 38 | May 5, 2017 | sec.gov |
| Nov 22, 2021 | Amendment | $6,612,667 | $5,930,006 | $682,661 | 39 | Apr 28, 2017 | sec.gov |
| Apr 14, 2021 | New notice | $25,625,000 | $15,000,000 | $10,625,000 | 1 | Apr 8, 2021 | sec.gov |
| Apr 14, 2021 | New notice | $5,000,000 | $5,000,000 | 1 | Apr 8, 2021 | sec.gov | |
| Nov 2, 2020 | Amendment | $2,975,746 | $2,597,057 | $378,689 | 38 | May 5, 2017 | sec.gov |
| Nov 2, 2020 | Amendment | $6,612,667 | $5,930,006 | $682,661 | 39 | Apr 28, 2017 | sec.gov |
| Oct 31, 2019 | Amendment | $2,975,746 | $2,597,057 | $378,689 | 38 | May 5, 2017 | sec.gov |
| Oct 31, 2019 | Amendment | $6,612,667 | $5,930,006 | $682,661 | 39 | Apr 28, 2017 | sec.gov |
| Nov 7, 2018 | Amendment | $6,612,667 | $5,930,006 | $682,661 | 39 | Apr 28, 2017 | sec.gov |
| Nov 7, 2018 | Amendment | $2,975,746 | $2,593,305 | $382,441 | 38 | May 5, 2017 | sec.gov |
| Nov 7, 2017 | Amendment | $6,612,667 | $5,750,000 | $862,667 | 39 | Apr 28, 2017 | sec.gov |
| Nov 7, 2017 | Amendment | $2,975,746 | $2,587,500 | $388,246 | 38 | May 5, 2017 | sec.gov |
| May 19, 2017 | New notice | $2,587,500 | $2,587,500 | 38 | May 5, 2017 | sec.gov | |
| May 2, 2017 | New notice | $5,750,000 | $5,750,000 | 39 | Apr 28, 2017 | sec.gov | |
| Feb 26, 2016 | New notice | $3,000,000 | $325,000 | $2,675,000 | 6 | Feb 11, 2016 | sec.gov |
| Feb 26, 2016 | Amendment | $5,175,000 | $5,175,000 | 40 | Dec 4, 2015 | sec.gov | |
| Dec 18, 2015 | New notice | $5,175,000 | $2,150,000 | $3,025,000 | 12 | Dec 4, 2015 | sec.gov |
| Mar 24, 2014 | New notice | $4,862,069 | $4,000,000 | $862,069 | 2 | Feb 28, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vicky G. Hahne | Executive Officer | |
| David F. Dalvey | Director | |
| Richard E. Buller | Director | |
| Polly A. Murphy | Director | |
| Richard J. Nigon | Director | |
| Leo T. Furcht | Director | |
| Lance G. Laing | Executive Officer, Director | |
| Brian F. Sullivan | Executive Officer, Director, Promoter |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Sep 22, 2025 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celcuity Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.